Suppr超能文献

将病毒用作纳米药物。

Using viruses as nanomedicines.

作者信息

van Kan-Davelaar H E, van Hest J C M, Cornelissen J J L M, Koay M S T

机构信息

Department of Biomolecular Nanotechnology, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.

出版信息

Br J Pharmacol. 2014 Sep;171(17):4001-9. doi: 10.1111/bph.12662.

Abstract

The field of nanomedicine involves the design and fabrication of novel nanocarriers for the intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although traditionally recognized for their ability to invade and infect host cells, viruses and bacteriophages have been engineered over the past decade as highly promising molecular platforms for the targeted delivery and treatment of many human diseases. Inherently biodegradable, the outer capsids of viruses are composed entirely of protein building blocks, which can be genetically or chemically engineered with molecular imaging reagents, targeting ligands and therapeutic molecules. While there are several examples of viruses as in vitro molecular cargo carriers, their potential for applications in nanomedicine has only recently emerged. Here we highlight recent developments towards the design and engineering of viruses for the treatment of cancer, bacterial infections and immune system-related diseases.

摘要

纳米医学领域涉及设计和制造新型纳米载体,用于细胞内递送治疗性物质或用于分子诊断。尽管病毒和噬菌体传统上因具有侵入和感染宿主细胞的能力而为人所知,但在过去十年中,它们已被改造成为极具前景的分子平台,用于多种人类疾病的靶向递送和治疗。病毒的外衣壳具有内在的可生物降解性,完全由蛋白质构建块组成,可以用分子成像试剂、靶向配体和治疗分子进行基因工程或化学工程改造。虽然有几个病毒作为体外分子货物载体的例子,但它们在纳米医学中的应用潜力直到最近才显现出来。在这里,我们重点介绍了病毒设计和工程改造在治疗癌症、细菌感染和免疫系统相关疾病方面的最新进展。

相似文献

1
Using viruses as nanomedicines.
Br J Pharmacol. 2014 Sep;171(17):4001-9. doi: 10.1111/bph.12662.
2
In vivo architectonic stability of fully de novo designed protein-only nanoparticles.
ACS Nano. 2014 May 27;8(5):4166-76. doi: 10.1021/nn4055732. Epub 2014 Apr 14.
3
Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.
Angew Chem Int Ed Engl. 2017 Feb 13;56(8):1964-1992. doi: 10.1002/anie.201606181. Epub 2017 Jan 24.
4
Phage-based delivery systems: engineering, applications, and challenges in nanomedicines.
J Nanobiotechnology. 2024 Jun 25;22(1):365. doi: 10.1186/s12951-024-02576-4.
5
Viral nanoparticles as platforms for next-generation therapeutics and imaging devices.
Nanomedicine. 2010 Oct;6(5):634-41. doi: 10.1016/j.nano.2010.04.005. Epub 2010 Apr 28.
6
Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
J Mater Chem B. 2019 Dec 11;7(48):7639-7655. doi: 10.1039/c9tb01842e.
7
Nanomedicine and Phage Capsids.
Viruses. 2018 Jun 6;10(6):307. doi: 10.3390/v10060307.
8
Designer adenoviruses for nanomedicine and nanodiagnostics.
Trends Biotechnol. 2009 Apr;27(4):220-9. doi: 10.1016/j.tibtech.2009.01.003. Epub 2009 Feb 27.
9
Therapeutic efficacy of nanomedicines for prostate cancer: An update.
Investig Clin Urol. 2016 Jan;57(1):21-9. doi: 10.4111/icu.2016.57.1.21. Epub 2016 Jan 11.
10
Killing cancer cells by targeted drug-carrying phage nanomedicines.
BMC Biotechnol. 2008 Apr 3;8:37. doi: 10.1186/1472-6750-8-37.

引用本文的文献

1
Engineering and Bio/Nanotechnological Applications of Virus Particles.
Subcell Biochem. 2024;105:823-878. doi: 10.1007/978-3-031-65187-8_22.
2
Virus-like particles derived from bacteriophage MS2 as antigen scaffolds and RNA protective shells.
Nanomedicine (Lond). 2024;19(12):1103-1115. doi: 10.2217/nnm-2023-0362. Epub 2024 Apr 17.
3
Virus-Based Biological Systems as Next-Generation Carriers for the Therapy of Central Nervous System Diseases.
Pharmaceutics. 2023 Jul 11;15(7):1931. doi: 10.3390/pharmaceutics15071931.
4
Bacteriophages as Biotechnological Tools.
Viruses. 2023 Jan 26;15(2):349. doi: 10.3390/v15020349.
5
Plug-and-Display Photo-Switchable Systems on Plant Virus Nanoparticles.
BioTech (Basel). 2022 Oct 21;11(4):49. doi: 10.3390/biotech11040049.
6
How promising are HIV-1-based virus-like particles for medical applications.
Front Cell Infect Microbiol. 2022 Oct 7;12:997875. doi: 10.3389/fcimb.2022.997875. eCollection 2022.
7
Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2.
Viruses. 2022 Jul 15;14(7):1553. doi: 10.3390/v14071553.
9
The viral capsid as novel nanomaterials for drug delivery.
Future Sci OA. 2021 Jul 14;7(9):FSO744. doi: 10.2144/fsoa-2021-0031. eCollection 2021 Oct.
10
Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical Trials.
Pharmaceutics. 2021 Mar 13;13(3):381. doi: 10.3390/pharmaceutics13030381.

本文引用的文献

1
Engineering of Brome mosaic virus for biomedical applications.
RSC Adv. 2012 May 7;2(9):3670-3677. doi: 10.1039/C2RA01376B. Epub 2012 Jan 23.
2
Phototriggered cargo release from virus-like assemblies.
Faraday Discuss. 2013;166:47-57. doi: 10.1039/c3fd00088e.
3
Evaluating efficacy of bacteriophage therapy against Staphylococcus aureus infections using a silkworm larval infection model.
FEMS Microbiol Lett. 2013 Oct;347(1):52-60. doi: 10.1111/1574-6968.12220. Epub 2013 Aug 6.
4
Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine.
J Biol Phys. 2013 Mar;39(2):301-25. doi: 10.1007/s10867-013-9314-z. Epub 2013 Apr 19.
5
Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds.
Wound Repair Regen. 2013 Jul-Aug;21(4):595-603. doi: 10.1111/wrr.12056. Epub 2013 Jun 11.
6
M13 virus based detection of bacterial infections in living hosts.
J Biophotonics. 2014 Aug;7(8):617-23. doi: 10.1002/jbio.201300010. Epub 2013 Apr 11.
7
Cucumber mosaic virus as drug delivery vehicle for doxorubicin.
Biomaterials. 2013 Jun;34(19):4632-42. doi: 10.1016/j.biomaterials.2013.03.017. Epub 2013 Mar 23.
8
Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care.
Plast Reconstr Surg. 2013 Feb;131(2):225-234. doi: 10.1097/PRS.0b013e31827e47cd.
9
Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
Eur J Pharm Biopharm. 2013 Aug;84(3):578-82. doi: 10.1016/j.ejpb.2012.12.022. Epub 2013 Jan 23.
10
Bacteriophage therapy in implant-related infections: an experimental study.
J Bone Joint Surg Am. 2013 Jan 16;95(2):117-25. doi: 10.2106/JBJS.K.01135.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验